Earnings History Data for ALX Oncology Holdings (ALXO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ALX Oncology Holdings

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		ALXO	ALX Oncology Holdings	80.00	-0.58	-0.78	0.00	ALX Oncology GAAP EPS of -$0.58 [11/8/2024 12:26 AM]	1.47	-0.04 (-2.98%)	1.56	0.05 (3.31%)	1.34 - 17.83	847,827	780,000	19,438
ALX Oncology GAAP EPS of -$0.58 [11/8/2024 12:26 AM]
08-08-2024	PM		ALXO	ALX Oncology Holdings Inc.	143.28	-0.76	-0.77	-0.84	ALX Oncology GAAP EPS of -$0.76 in-line [8/9/2024 3:06 AM]	2.63	0.0 (0.00%)	2.68	0.05 (1.90%)	2.45 - 17.83	1,435,189	3,250,000	6,938
ALX Oncology GAAP EPS of -$0.76 in-line [8/9/2024 3:06 AM]
07-03-2024	AH		ALXO	ALX Oncology Holdings	736.00	-0.93	-0.84	0.00		15.16	-1.08 (-6.65%)	14.59	-1.65 (-10.16%)	3.94 - 17.42	869,920	410,000	8,795
Stifel downgrades ALX Oncology to hold, sees evorpacept as fully valued [3/8/2024 3:49 PM]
10-08-2023	PM		ALXO	ALX Oncology Holdings	206.00	-0.84	-0.85	0.00	ALX Oncology GAAP EPS of -$0.84 beats by $0.07 [8/11/2023 4:14 AM]	5.04	0.0 (0.00%)	5.04	0.0 (0.00%)	4.23 - 15.39	102,958	100,000	1,893
ALX Oncology GAAP EPS of -$0.84 beats by $0.07 [8/11/2023 4:14 AM]
11-05-2023	AH		ALXO	ALX Oncology Holdings	266.00	-0.58	-0.84	0.00	ALX Oncology GAAP EPS of -$0.74 [5/11/2023 5:40 PM]	6.59	0.32 (5.10%)	6.46	0.19 (3.03%)	4.23 - 15.39	379,511	260,000	1,001
ALX Oncology GAAP EPS of -$0.74 [5/11/2023 5:40 PM]
09-03-2023	AH		ALXO	ALX Oncology Holdings	260.00	-0.75	-0.91	0.00		5.43	-0.44 (-7.50%)	6.16	0.29 (4.94%)	5.09 - 20.40	366,879	160,000	1,675

08-11-2022	AH	4:00 PM ET (Nov 8)	ALXO	ALX Oncology Holdings	498.00	-0.87	-0.75	0.00	ALX Oncology GAAP EPS of -$0.87 misses by $0.08 [11/8/2022 5:06 PM]	12.38	-0.12 (-0.96%)	12.50	0.0 (0.00%)	5.82 - 47.03	201,087	170,000	1,836
ALX Oncology GAAP EPS of -$0.87 misses by $0.08 [11/8/2022 5:06 PM] ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights [Nov-08-22 04:01PM]
08-08-2022	AH		ALXO	ALX Oncology Holdings	442.00	-0.81	-0.66	0.00	ALX Oncology GAAP EPS of -$0.81 misses by $0.18 [8/8/2022 5:39 PM]	11.76	0.0 (0.00%)	11.76	0.0 (0.00%)	5.82 - 81.19	275,914	260,000	2,328
ALX Oncology GAAP EPS of -$0.81 misses by $0.18 [8/8/2022 5:39 PM] ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights [Aug-08-22 04:01PM]
09-05-2022	AH		ALXO	ALX Oncology Holdings	450.00	-0.60	-0.77	0.00	ALX Oncology GAAP EPS of -$0.60 beats by $0.11 [5/9/2022 5:22 PM]	9.78	0.48 (5.16%)	9.30	0.0 (0.00%)	9.15 - 81.19	492,766	360,000	1,291
ALX Oncology GAAP EPS of -$0.60 beats by $0.11 [5/9/2022 5:22 PM]
28-02-2022	PM		ALXO	ALX Oncology Holdings	664.00	-0.70	-0.63	0.00	ALX Oncology GAAP EPS of -$0.70 misses by $0.08 [2/28/2022 7:18 AM]	18.10	1.25 (7.42%)	16.85	0.0 (0.00%)	13.22 - 88.55	293,090	540,000	4,282
ALX Oncology GAAP EPS of -$0.70 misses by $0.08 [2/28/2022 7:18 AM] ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones [Feb-28-22 07:00AM]
12-08-2021	AH		ALXO	Alx Oncology Holdings Inc.	2,615	-0.40	-0.42	0.00		66.44	0.03 (0.05%)	66.41	0.0 (0.00%)	32.51 - 117.45	122,028	380,000	2,476
ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights [Aug-12-21 04:05PM]
17-05-2021	AH	4:05 PM ET (May 17)	ALXO	Alx Oncology Holdings Inc.	2,116	-0.35	-0.46	0.00	ALX Oncology EPS beats by $0.09 [5/17/2021 4:40 PM]	55.49	0.70 (1.28%)	54.79	0.0 (0.00%)	28.01 - 117.45	264,487	180,000	2,450
ALX Oncology EPS beats by $0.09 [5/17/2021 4:40 PM] ALX Oncology Reports First Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights [May-17-21 04:05PM] ALX Oncology Announces Upcoming Virtual Investor Conference Participation [May-18-21 07:00AM]
18-03-2021	AH		ALXO	ALX Oncology Holdings Inc.	2,850	-0.48	-0.36	0.00	ALX Oncology EPS misses by $0.15 [3/18/2021 4:35 PM]	62.72	-10.15 (-13.92%)	80.76	0.0 (0.00%)	28.01 - 117.45	1,176,366	280,000	1,512
ALX Oncology EPS misses by $0.15 [3/18/2021 4:35 PM] ALX Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones [Mar-18-21 04:05PM]